Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome

PURPOSE: In this era of molecular diagnostics, prediction of clear-cell renal cell cancer (ccRCC) survival requires optimization, as current prognostic markers fail to determine individual patient outcome. Epigenetic events are promising molecular markers. Promoter CpG island methylation of cysteine...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Deckers, Ivette A.G., Schouten, Leo J., Van Neste, Leander, van Vlodrop, Iris J.H., Soetekouw, Patricia M.M.B., Baldewijns, Marcella M.L.L., Jeschke, Jana, Ahuja, Nita, Herman, James G., van den Brandt, Piet A., van Engeland, Manon
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4612631/
https://ncbi.nlm.nih.gov/pubmed/25904753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2049
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki